To evaluate the effects of BA and tolvaptan in vivo we used an early and rapid model of ADPKD progression, the Pkd1fl/fl; Pax8-rtTA; Tet-O-Cre mouse. Here, PAX8 is linked to autosomal dominant polycystic kidney disease.